Genetic polymorphisms in the tumor necrosis factor locus influence non- Hodgkin's lymphoma outcome

Blood

Volumn 91, Issue 10, 1998, Pages 3574-3581

  Warzocha, Krzysztof ^b   Ribeiro, Patricia ^b   Bienvenu, Jacques ^b   Roy, Pascal ^b   Charlot, Carole ^b   Rigal, Dominique ^b   Coiffier, Bertrand ^b   Salles, Gilles ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CENTROMERE; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0032525156     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3574.3574_3574_3581     Document Type: Article

References (43)

1. Eugster HP, Müller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly G, Le Hir M, di Padova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B: Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-a double-deficient mice. Int Immunol 8:23, 1996
2. Le Hir M, Bluethmann H, Kosco-Vilbois MH, Muller M, di Padova F, Moore M, Ryffel B, Eugster HP: Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med 183:2367, 1996
3. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G: Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397, 1996
4. Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717, 1996
5. Barnes PJ, Karin M: Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066, 1996
6. Salles G, Bienvenu J, Bastion Y, Barbier Y, Doche C, Warzocha K, Gutowski MC, Rieux C, Coiffier B: Elevated circulating levels of TNFα and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol 93:352, 1996
7. Warzocha K, Salles G, Bienvenu J, Bastion Y, Dumontet C, Renard N, Neidhardt EM, Coiffier B: The tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol 15:499, 1997
8. Cordingley FT, Hoffbrand AV, Heslop HE, Turner M, Bianchi A, Reittie JE, Vyakarnam A, Meager A, Brenner MK: Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignan-cies. Lancet 1:969, 1988
9. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A: Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167: 1211, 1988
10. Tracey KJ: TNF and Mae West or: Death from too much of a good thing. Lancet 345:75, 1995
11. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557, 1993
12. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS: Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211:833, 1995
13. D'Alfonso SD, Richiardi PM: A polymorphic variation in a putative regulation box of the TNFα promoter region. Immunogenetics 39:150, 1994
14. Messer G, Spengler U, Jung MC, Honold G, Blömer K, Pape GR, Riethmüller G, Weiss EH: Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173:209, 1991
15. Takashiba S, Shapira L, Amar S, Van Dyke TE: Cloning and characterization of human TNFα promoter region. Gene 131:307, 1993
16. Kroeger KM, Abraham LJ: Identification of an AP-2 element in the -323 to -285 region of the TNF-alpha gene. Biochem Mol Biol Int 40:43, 1996
17. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195, 1997
18. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224, 1993
19. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, Mann DL: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 2:405, 1996
20. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508, 1994
21. Booy R, Nadel S, Hibberd M, Levin M, Newport MJ: Genetic influence on cytokine production in meningococcal disease. Lancet 349:1176, 1997
22. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233, 1990
23. Mulcahy B, Waldron-Lynch F, McDermott MF, Adams C, Amos CI, Zhu DK, Ward RH, Clegg DO, Shanahan F, Molloy MG, O'Gara F: Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 59:676, 1996
24. International Lymphoma Study Group: A revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
25. Zhu KY, Clark JM: Addition of a competitive primer can dramatically improve the specificity of PCR amplification of specific alleles. Biotechniques 21:586, 1996
26. The International Non-Hodgkin's Lymphoma Prognostic Factor Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993
27. Webb GC, Chaplin DD: Genetic variability at the human tumor necrosis factor loci. J Immunol 145:1278, 1990
28. Peruccio D, D'Alfonso S, Borelli I, Amoroso A, Mazzola G, Marsico D, Bersanti M, Richiardi P: Distribution of tumor necrosis factor alleles (NcoI RFLP) and their relationship to HLA haplotypes in an Italian population. Hum Hered 43:103, 1993
29. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS: Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphism in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scan J Immunol 43:456, 1996
30. Ross ME, Caligiuri MA: Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89:910, 1997
31. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348, 1995
32. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J Exp Med 182:389, 1995
33. Sallusto F, Nicolo C, De Maria R, Corinti S, Testi R: Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med 184:2411, 1996
34. Kobayashi D, Watanabe N, Yamauchi N, Tsuji N, Sato T, Niitsu Y: Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood 89:2472, 1997
35. Trentin L, Zambello R, Agostini C, Siviero F, Adami F, Marcolongo R, Raimondi R, Chisesi T, Pizzolo G, Semenzato G: Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 81:752, 1993
36. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P: Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 23:1725, 1996
37. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL: Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease? Br J Rheumatol 36:516, 1997
38. Mordmuller BG, Metzger WG, Juillard P, Brinkman BM, Verweij CL, Grau GE, Kremsner PG: Tumor necrosis factor in Plasmodium falciparum malaria: High plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur Cytokine Netw 8:29, 1997
39. Brinkman BM, Keet IP, Miedema F, Verweij CL, Klein MR: Polymorphisms within the human tumor necrosis factor-alpha promoter region in human immunodeficiency virus type 1-seropositive persons. J Infect Dis 175:188, 1997
40. Shipp MA: Can we improve upon the International Index? Ann Oncol 8:43, 1997 (suppl 1)
41. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosupression by glucocorticoids: Inhibition of NF-KB activity through induction of IκB synthesis. Science 270:286, 1995
42. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105, 1994
43. Stack WA, Mann SD, Roy AJ, Heath P, Sopwith M, Freeman J, Holmes G, Long R, Forbes A, Kamm MA: Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet 349:521, 1997